Una cueva sepulcral en la ladera de Chabaso (Igueste de Candelaria, isla de Tenerife)

En el mes de octubre del año 1974 llegó hasta nosotros la noticia de que un gnipo de jóvenes había realizado un hallazgo arqueológico en una de las laderas de la Montaña de Araya (Candelaria). El yacimiento presentaba en superficie algunas cuentas cerámicas ' y restos humanos. Ante la posibilidad de que Ia cueva fuera saqueada y ante el posible riesgo de que su contenido se desprendiera, pues el muro que lo contenía estaba en estado no demasiado fiable, decidimos realizar su excavación.Peer reviewe

Revista de Vertebrados de la Estación Biológica de Doñana

Algunas variables que influyen la diferenciación por edades del pejerrey (Atherina Hepseti) boyeri Risso 1810)Variations in weight and gonad size in dunlins (Calidris alpina) in the Guadiana estuary, sw Spain.Evolución estacional de la comunidad de aves en un encinar de Sierra Nevada.Las comunidades de aves invernantes en cuatro medios diferentes de la provincia de Córdoba.Estrategias de nidificación en Passer domesticus.Reproducción de la urraca (Pica pica) en Sierra Morena (Andalucía).La distribución de las currucas (G. Sylvia, Cl. Aves) en el Sistema Central (España)Interacciones entre los patos buceadores en una laguna meridional española.Distancia de huída en aves.Lugares de reposo diurno de algunos quirópteros en los Llanos de Venezuela.Datos de distribución de Emys orbicularis en la provincia de CádizSobre la alimentación del avetoro común (Botaurus stellaris) en España.Sobre la distribución pasada y alimentación del quebrantahuesos (Gypaetus barbatus L. 1798) en España.Datos sobre la alimentación de avoceta (Recurvirrostra avosetta) en el estuario del Guadiana.Status de la pazaga piqirroja (Hydroprogne caspia) en el SO españolDatos sobre alimentación de dos Phalaropus fulicarius en el SO de EspañaNeomys anomalus, nuevas citas para GranadaPrimera captura de una foca común en el suroeste de IberiaPeer reviewe

The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease

Interleukin 17 (IL-17) is an effector cytokine that plays a key role in the pathogenesis of both psoriasis and metabolic-associated fatty liver disease (MAFLD), a condition that is more prevalent and severe in patients with psoriasis. In liver inflammation, IL-17 is mainly produced by CD4+ T (TH17) and CD8+ T cells (Tc17), although numerous other cells (macrophages, natural killer cells, neutrophils and Tγδ cells) also contribute to the production of IL-17. In hepatocytes, IL-17 mediates systemic inflammation and the recruitment of inflammatory cells to the liver, and it is also implicated in the development of fibrosis and insulin resistance. IL-17 levels have been correlated with progression from MAFLD to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Clinical trials have shown that inhibiting IL-17A in patients with psoriasis could potentially contribute to the improvement of metabolic and liver parameters. A better understanding of the key factors involved in the pathogenesis of these chronic inflammatory processes could potentially lead to more efficient treatment for both psoriasis and MAFLD, and help to develop holistic strategies to improve the management of these patients

The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease

Interleukin 17 (IL-17) is an effector cytokine that plays a key role in the pathogenesis of both psoriasis and metabolic-associated fatty liver disease (MAFLD), a condition that is more prevalent and severe in patients with psoriasis. In liver inflammation, IL-17 is mainly produced by CD4+ T (TH17) and CD8+ T cells (Tc17), although numerous other cells (macrophages, natural killer cells, neutrophils and Tγδ cells) also contribute to the production of IL-17. In hepatocytes, IL-17 mediates systemic inflammation and the recruitment of inflammatory cells to the liver, and it is also implicated in the development of fibrosis and insulin resistance. IL-17 levels have been correlated with progression from MAFLD to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Clinical trials have shown that inhibiting IL-17A in patients with psoriasis could potentially contribute to the improvement of metabolic and liver parameters. A better understanding of the key factors involved in the pathogenesis of these chronic inflammatory processes could potentially lead to more efficient treatment for both psoriasis and MAFLD, and help to develop holistic strategies to improve the management of these patient

The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease

Interleukin 17 (IL-17) is an effector cytokine that plays a key role in the pathogenesis of both psoriasis and metabolic-associated fatty liver disease (MAFLD), a condition that is more prevalent and severe in patients with psoriasis. In liver inflammation, IL-17 is mainly produced by CD4+ T (TH17) and CD8+ T cells (Tc17), although numerous other cells (macrophages, natural killer cells, neutrophils and Tγδ cells) also contribute to the production of IL-17. In hepatocytes, IL-17 mediates systemic inflammation and the recruitment of inflammatory cells to the liver, and it is also implicated in the development of fibrosis and insulin resistance. IL-17 levels have been correlated with progression from MAFLD to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Clinical trials have shown that inhibiting IL-17A in patients with psoriasis could potentially contribute to the improvement of metabolic and liver parameters. A better understanding of the key factors involved in the pathogenesis of these chronic inflammatory processes could potentially lead to more efficient treatment for both psoriasis and MAFLD, and help to develop holistic strategies to improve the management of these patients